DK1330262T3 - Anvendelse af enzymer udvundet fra ciliater som lægemidler til fremme af fordöjelsen - Google Patents

Anvendelse af enzymer udvundet fra ciliater som lægemidler til fremme af fordöjelsen

Info

Publication number
DK1330262T3
DK1330262T3 DK01992585T DK01992585T DK1330262T3 DK 1330262 T3 DK1330262 T3 DK 1330262T3 DK 01992585 T DK01992585 T DK 01992585T DK 01992585 T DK01992585 T DK 01992585T DK 1330262 T3 DK1330262 T3 DK 1330262T3
Authority
DK
Denmark
Prior art keywords
ciliates
drugs
promote digestion
enzymes derived
enzymes
Prior art date
Application number
DK01992585T
Other languages
English (en)
Inventor
Marcus Hartmann
Original Assignee
Cilian Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cilian Ag filed Critical Cilian Ag
Application granted granted Critical
Publication of DK1330262T3 publication Critical patent/DK1330262T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK01992585T 2000-11-02 2001-11-02 Anvendelse af enzymer udvundet fra ciliater som lægemidler til fremme af fordöjelsen DK1330262T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10054239 2000-11-02
PCT/EP2001/012740 WO2002036156A1 (de) 2000-11-02 2001-11-02 Verwendung von aus ciliaten gewonnenen enzymen als verdauungsfördernde arzneimittel

Publications (1)

Publication Number Publication Date
DK1330262T3 true DK1330262T3 (da) 2005-09-19

Family

ID=7661849

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01992585T DK1330262T3 (da) 2000-11-02 2001-11-02 Anvendelse af enzymer udvundet fra ciliater som lægemidler til fremme af fordöjelsen

Country Status (17)

Country Link
US (2) US20040033220A1 (da)
EP (1) EP1330262B1 (da)
JP (1) JP4139215B2 (da)
CN (1) CN1262308C (da)
AT (1) ATE295737T1 (da)
AU (2) AU2366602A (da)
CA (1) CA2427537A1 (da)
DE (1) DE50106273D1 (da)
DK (1) DK1330262T3 (da)
ES (1) ES2239686T3 (da)
HK (1) HK1057861A1 (da)
IL (2) IL155515A0 (da)
NO (1) NO20031979L (da)
PL (1) PL204599B1 (da)
PT (1) PT1330262E (da)
RU (1) RU2299074C2 (da)
WO (1) WO2002036156A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2421538T3 (es) * 2003-10-29 2013-09-03 Cystic Fibrosis Foundation Therapeutics Inc Proteasas no pancreáticas para controlar la concentración de colecistocinina (CCK) en plasma y para tratar el dolor
WO2005092370A1 (en) * 2004-03-22 2005-10-06 Solvay Pharmaceuticals Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
WO2005098427A2 (en) * 2004-04-05 2005-10-20 Arbab Saccharides Science & Technology Co. Ltd Method, composition and device for treating starch related diseases
WO2005099748A1 (de) * 2004-04-13 2005-10-27 Cilian Ag Rekombinante lysosomale enzyme mit ciliaten-typischem glykosylierungsmuster für die therapie
WO2007014896A1 (en) 2005-07-29 2007-02-08 Solvay Pharmaceuticals Gmbh Processes for the manufacture of sterilized pancreatin powder
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
WO2007053619A2 (en) * 2005-11-01 2007-05-10 Bio-Cat, Inc. A composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
EP2328566A1 (en) * 2008-09-30 2011-06-08 DSM IP Assets B.V. Enzyme composition and application thereof in the treatment of pancreatic insufficiency
GB201501081D0 (en) * 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion
WO2022214705A1 (en) * 2021-04-09 2022-10-13 Cilian Ag Purification of proteins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454566B (sv) * 1984-04-24 1988-05-16 Lars G I Hellgren Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus
DE59209604D1 (de) * 1991-07-01 1999-02-11 Basf Ag Verwendung von lipasen zur herstellung von arzneimitteln
DE19524307A1 (de) * 1995-07-07 1997-01-09 Hoechst Ag Verfahren zur Massenkultivierung von Ciliaten
DE19724845A1 (de) * 1996-08-28 1998-03-05 Solvay Pharm Gmbh Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen
US6846481B1 (en) * 1999-02-04 2005-01-25 University Of Georgia Research Foundation, Inc. Recombinant expression of heterologous nucleic acids in protozoa
US6539128B1 (en) * 1999-04-16 2003-03-25 Macronix International Co., Ltd. Method and apparatus for interpolation
US6543100B1 (en) * 2001-09-24 2003-04-08 Christopher J. Finley Test tube retention system

Also Published As

Publication number Publication date
CA2427537A1 (en) 2002-05-10
ATE295737T1 (de) 2005-06-15
JP4139215B2 (ja) 2008-08-27
CN1262308C (zh) 2006-07-05
RU2299074C2 (ru) 2007-05-20
DE50106273D1 (de) 2005-06-23
ES2239686T3 (es) 2005-10-01
EP1330262A1 (de) 2003-07-30
EP1330262B1 (de) 2005-05-18
CN1484530A (zh) 2004-03-24
IL155515A (en) 2009-02-11
WO2002036156A1 (de) 2002-05-10
NO20031979D0 (no) 2003-04-30
NO20031979L (no) 2003-06-30
IL155515A0 (en) 2003-11-23
US20040033220A1 (en) 2004-02-19
US20080292610A1 (en) 2008-11-27
JP2004512375A (ja) 2004-04-22
HK1057861A1 (en) 2004-04-23
AU2002223666B2 (en) 2006-08-24
PL204599B1 (pl) 2010-01-29
AU2366602A (en) 2002-05-15
PT1330262E (pt) 2005-07-29
PL361630A1 (en) 2004-10-04

Similar Documents

Publication Publication Date Title
DK1330262T3 (da) Anvendelse af enzymer udvundet fra ciliater som lægemidler til fremme af fordöjelsen
IL151313A0 (en) Lipase containing pharmaceutical compositions
DK1268847T3 (da) Ubiquitin-ligaseassay
HK1060373A1 (en) Enzymes having alpha amylase activity and methods of use thereof
DK1162995T3 (da) Enzymer til behandling af diabetes mellitus type I
DK1755656T3 (da) Enzymer til farmaceutisk anvendelse
BR9908280A (pt) Inibidores de enzimas de fosfolipase
MXPA02002901A (es) Enzimas de ruta de enfocado lisosomal.
ES2572160T3 (es) Una nueva preparación farmacéutica para preeclampsia
EA201171291A1 (ru) Кормовая добавка
WO2006063055A3 (en) Enzyme conjugates for use as detoxifying agents
MY183252A (en) Kallirein 7 modulators
DE60137978D1 (de) Zusammensetzung zur förderung des haarwachstums
DE60042209D1 (de) Enzymatische synthese von deoxyribonucleotiden
NO20042601L (no) Ny peptid med angiotensinkonvertasehemmende effekt
AU2002223666A1 (en) Use of enzymes obtained from ciliates as medicaments for promoting digestion
DE60018422D1 (de) Typ v pde-hemmer zur behandlung von mukoviszidose
ATE267863T1 (de) Flüssige entkalkungs-zusammensetzung
WO2007085428A3 (de) Mund-und zahnpflege und-remigungsmittel mit enzymen'
SI1539815T1 (sl) Kristalna struktura encima, ki pretvarja angiotenzin (ACE), in njegove uporabe
WO2002093127A3 (en) Methods and reagents for identifying insulin response modulators and therapeutic uses therefor
DE60033943D1 (de) Schwefelfreie enzyme
ATE273394T1 (de) Wirts-vektor-systeme zur phosphatregulierten überproduktion von polypeptiden in bacillus
PL359727A1 (en) Crystalline pharmaceutical
MX2009004611A (es) Formulaciones de inhibidores de enzimas de fosfolipasa.